Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology
Sponsored By: Samra Brouk (Democratic)
In Committee
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & Cosponsors
Sponsor
Samra Brouk
Democratic • Senate
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
No roll call votes available for this bill.
Actions Timeline
REFERRED TO HEALTH
1/7/2026SenateREFERRED TO HEALTH
1/8/2025Senate
Bill Text
Original
1/7/2025
Related Bills
S 10166, Provides for emergency appropriation for the period April 1, 2026 through May 6, 2026
S 10167, Relates to the administration of certain funds and accounts related to the 2026-2027 budget, authorizing certain payments and transfers
S 10103, Provides for emergency appropriation for the period April 1, 2026 through May 4, 2026
S 10102, Provides for the implementation of certain parts of the state fiscal plan for the 2026-2027 state fiscal year
S 10060, Provides for emergency appropriation for the period April 1, 2026 through April 30, 2026
S 9999, Provides for emergency appropriation for the period April 1, 2026 through April 27, 2026